Dr. Shao Guang Liu | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Associate Professor | Gansu Provincial Hospital | China

Dr. Liushaoguang is an accomplished associate professor and clinical expert in trauma and emergency medicine, currently contributing to the advancement of medical research and patient care at Gansu Provincial Hospital. His research primarily focuses on emergency trauma management and sepsis-induced peritonitis, with a strong emphasis on molecular and immunological mechanisms underlying trauma-related complications. Dr. Liushaoguang has led and completed several significant provincial-level projects, including studies on the construction of trauma care system management models and investigations into dendritic cell function transformation and immune paralysis in sepsis. His scholarly contributions reflect a deep integration of clinical insight and biomedical research aimed at improving critical care outcomes. His work has been widely recognized in academic circles, with a citation record of 160 citations across 11 documents and an h-index of 6 on Scopus, demonstrating the impactful nature of his research. On Google Scholar, his publications have also garnered substantial attention from the scientific community. In addition to his research achievements, Dr. Liushaoguang serves on the editorial board of the Chinese Journal of Traumatology, further underscoring his commitment to advancing medical knowledge. His published works explore various aspects of sepsis, endothelial function, gene methylation, and circular RNA mechanisms in inflammatory responses.

Profile

Scopus

Featured Publications

  • Liushaoguang. (2023). Four differentially methylated gene pairs to predict the prognosis for early stage. Frontiers in Genetics.

  • Liushaoguang. (2023). Circular RNA circ_0001105 protects the intestinal barrier of septic rats by inhibiting inflammation. BMC Gastroenterology.

  • Liushaoguang. (2022). Transcriptomics changes in the peritoneum of mice with lipopolysaccharide-induced peritonitis. Scientific Reports.

  • Liushaoguang. (2022). Endothelial progenitor cell-derived exosomal miRNA-31 alleviates septic peritonitis. Cell Death Discovery.

  • Liushaoguang. (2021). Research on the construction of the trauma care system management model in Gansu Province. Chinese Journal of Traumatology.

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.

Jana Behunova | Medical | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Jana Behunova | Medical | Best Researcher Award

Dr. Jana Behunova-Specialist in Medical Genetics, Medical University of Vienna/Institute of Medical Genetics, Austria.

Dr. Jana Behunova, M.D., Ph.D., is a distinguished Slovak medical geneticist and pediatrician currently based in Vienna, Austria. Born in Košice, Slovakia, she has dedicated over two decades to the academic, clinical, and research dimensions of medical genetics and pediatrics. She earned both her medical and doctoral degrees in Slovakia and has gained global insights through international fellowships in Sweden, the USA, Israel, and the Czech Republic. Currently serving as an Assistant Professor at the Institute of Medical Genetics, Medical University of Vienna, Dr. Behunova combines teaching, patient care, and genetic counseling with a passion for rare disorders and congenital malformations.

Publication Profile

🎓 Education Background

Dr. Jana Behunova’s academic journey began at the Pavol Jozef Šafárik University, Faculty of Medicine, Košice, where she earned her M.D. between 1990 and 1996. She continued her advanced studies in medical genetics and pediatrics through doctoral programs at the same institution and later at Comenius University in Bratislava, completing her Ph.D. between 2002 and 2008. Her academic excellence is further complemented by certifications in Pediatrics (I and II) and Medical Genetics, recognized across the European Union. This robust educational foundation paved the way for her specialization in genetic disorders, clinical pediatrics, and rare disease research across Europe and beyond.

🏥 Professional Experience

Dr. Behunova’s professional career commenced with residency roles in Prešov and Košice, Slovakia, where she trained in pediatrics. From 1999 to 2012, she served as Assistant Professor in Pediatrics at Pavol Jozef Šafárik University. Her academic pursuits then led her to the Medical University of Vienna, Austria, where she has held a long-standing role as Assistant Professor at the Institute of Medical Genetics since 2012. Her diverse experience spans clinical diagnostics, academic instruction, genetic counseling, and research leadership. Dr. Behunova’s multidisciplinary experience reflects her dedication to pediatric and genetic healthcare, both in her native Slovakia and internationally.

🏅 Awards and Honors

Dr. Jana Behunova has been honored for her contribution to European research networks and rare disease policies. She played a pivotal role in the Europlan project, contributing to the development of national guidelines for rare diseases in Slovakia. She also authored contributions to the 2011 Report on Rare Disease Activities in Europe by the EU Committee of Experts. Her international collaborations with renowned experts in Israel, Sweden, the USA, and Austria, alongside participation in elite training seminars such as the Salzburg Open Medical Institute and the ESHG’s genetic counseling programs, further underline her recognition as a leader in her field.

🔬 Research Focus

Dr. Behunova’s research lies at the intersection of medical genetics, pediatric anomalies, and congenital malformation syndromes. She has contributed to significant projects such as the analysis of facial cleft-related syndromes using micro-CT on historical specimens and studies on gene polymorphisms in orofacial clefts. Her work also delves into neural tube defects, jaundice syndromes in Roma populations, and birth defects in fetal archives. Through collaborations with eminent institutions across Europe and the USA, Dr. Behunova investigates how genetic variations influence developmental disorders, positioning her at the forefront of translational genetics and syndromic research within pediatric medicine.

🧾 Conclusion

Dr. Jana Behunova exemplifies dedication, innovation, and excellence in medical genetics and pediatrics. Her international training, bilingual fluency, and extensive contributions to research and education place her among Europe’s respected clinician-scientists. From Slovakia to Austria, and across borders, she continues to advance the understanding of rare diseases, congenital syndromes, and genetic counseling. With a passion for both clinical practice and academic mentoring, Dr. Behunova’s lifelong commitment impacts patients, students, and the broader scientific community alike. Her work not only advances healthcare standards but also enriches the global conversation on genetics and pediatric disorders.

📚 Top Publications Notes

Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Assoc. Prof. Dr. Paramita Basu Mukherjee | Health Sciences | Best Researcher Award

Associate Professor, New York College of Podiatric Medicine, United States

Dr. Paramita Basu is a distinguished scientist and educator specializing in infectious diseases, pharmaceutical sciences, and microbiology. Currently, she serves as an Associate Professor and Director of Infectious Diseases at the New York College of Podiatric Medicine and an Associate Professor of Pharmaceutical & Biomedical Sciences at Touro College of Pharmacy, New York. With a Ph.D. in Biological Sciences from St. John’s University, she has made significant contributions to research on biofilms, antibiotic resistance, and innovative learning methodologies. As a dedicated academic leader, she also chairs the Curriculum Committee at Touro College of Pharmacy, shaping the future of pharmaceutical education.

Publication Profile

🎓 Education

Dr. Basu earned her Ph.D. in Biological Sciences from St. John’s University, Queens, New York (2003-2008). Her research during this period focused on microbial resistance and biofilm control mechanisms, laying the foundation for her impactful work in microbiology and pharmaceutical sciences.

💼 Experience

With over a decade of experience in academia, Dr. Basu has held key positions in medical and pharmaceutical education. Since 2009, she has been an Associate Professor at Touro College of Pharmacy, where she teaches pharmaceutical and biomedical sciences. In 2022, she joined the New York College of Podiatric Medicine as the Director of Infectious Diseases, focusing on pre-clinical sciences and microbiology. Her expertise extends to curriculum development, interdisciplinary education, and research on antibiotic resistance in clinical settings.

🏆 Awards and Honors

Dr. Basu has received multiple recognitions for her outstanding research and academic contributions. She has been acknowledged for her pioneering work in antimicrobial resistance, biofilm studies, and the integration of audiovisual learning in medical education. Her research has been published in top-tier scientific journals, reflecting her impact on global microbiology and pharmaceutical sciences.

🔬 Research Focus

Dr. Basu’s research interests revolve around biofilm formation, antibiotic resistance mechanisms, and innovative drug therapies. Her work has significantly contributed to understanding Pseudomonas aeruginosa biofilms, Vibrio gazogenes interactions, and novel antibiotic treatments. Additionally, she explores the role of multimedia learning tools in medical education, aiming to improve student engagement and knowledge retention in pharmaceutical sciences.

🔎 Conclusion

Dr. Paramita Basu is a renowned microbiologist, educator, and researcher with a passion for antimicrobial resistance and innovative learning in pharmaceutical sciences. Her groundbreaking work in infectious disease research and medical education has solidified her position as a leader in the field. With a commitment to scientific advancement and student success, she continues to make a significant impact in pharmaceutical and biomedical sciences. 🚀

📚 Publications

Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review – Acta Microbiologica Hellenica (2025) [🔗DOI: 10.3390/amh70010009]

Integration of an Audiovisual Learning Resource in a Podiatric Medical Infectious Disease Course: Multiple Cohort Pilot Study – JMIR Medical Education (2025) [🔗DOI: 10.2196/55206]

Study of the impact of introducing a multimedia learning tool in podiatric medical courses – Journal of Foot and Ankle Research (2024) [🔗DOI: 10.1002/jfa2.12018]

Antibiotic-Induced Changes in Efflux Transporter Expression: A Key Factor in Pseudomonas aeruginosa Biofilm Resistance – Journal of Experimental Biology and Agricultural Sciences (2024) [🔗DOI: 10.18006/2024.12(2).274.283]

Vibrio gazogenes-dependent disruption of aflatoxin biosynthesis in Aspergillus flavus – Frontiers in Microbiology (2023) [🔗DOI: 10.3389/fmicb.2023.1208961]

The Effect of Antibiotic Treatment and Gene Expression of Mex B Efflux Transporters on the Resistance in Pseudomonas Aeruginosa Biofilms – Applied Microbiology (2023) [🔗DOI: 10.3390/applmicrobiol3030049]

Surveillance of SARS-CoV-2 RNA in open-water sewage canals – Access Microbiology (2022) [🔗DOI: 10.1099/acmi.0.000318]

Antimicrobial Resistance in Pseudomonas aeruginosa Biofilms – Journal of Pure and Applied Microbiology (2021) [🔗DOI: 10.22207/JPAM.15.4.79]

Maria Asunción Aguilar | Health Sciences | Women Researcher Award

Published on by Computer Scientists Awards

Prof Dr. Maria Asunción Aguilar | Health Sciences | Women Researcher Award

Catedrática de Universidad, Universitat de Valencia, Spain

👩‍🔬 Maria A. Aguilar (also known as Maria Asunción Aguilar) is a Full Professor at the University of Valencia in the Department of Psychobiology. With a research focus on psychopharmacology and physiological psychology, she has made significant contributions to understanding the brain mechanisms underlying addiction and stress resilience. Since November 2017, she has held the prestigious position of Catedrático at the University of Valencia.

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Research in Psychobiology: María A. Aguilar is a full professor of Psychobiology at the University of Valencia, focusing on neuropsychopharmacology and physiological psychology. Her work on the interaction between social stress, drug addiction, and brain function, particularly in the context of cocaine and MDMA, contributes valuable insights to women’s health and psychology, making her a strong contender.
  2. Prolific Publication Record: With 122 published works, Aguilar’s research covers cutting-edge topics such as the role of social stress in drug addiction and the therapeutic effects of substances like cannabidiol. These areas have significant implications for mental health treatments, relevant to women’s health challenges.
  3. Leadership and Experience: She has held prominent academic roles, including being a full professor since 2017 and previously a tenured professor since 2002. Her leadership in academic settings and sustained research output strengthens her profile for the award.
  4. Innovative Contributions to Neuroscience: Aguilar’s studies on glutamatergic receptors and their role in the brain’s response to social defeat and drug addiction present novel approaches to understanding mental health disorders, making her a thought leader in neuroscience.

Areas for Improvement:

  1. Specific Focus on Women’s Health: Although her research addresses critical aspects of mental health, especially addiction and stress, a more direct focus on gender-specific issues in psychopharmacology, such as how these conditions uniquely impact women, could make her case stronger for an award dedicated to women’s research.
  2. Outreach and Public Engagement: While her academic contributions are significant, further involvement in public health initiatives or policy impact related to women’s mental health might enhance her candidacy. Increasing visibility in terms of applying her research to real-world settings could further strengthen her application.

Education

🎓 Maria A. Aguilar completed her specialization in Psychopharmacology and Physiological Psychology, with a focus on understanding the neural circuits involved in addiction and behavior. Her doctoral thesis was supervised by renowned experts Jose Miñarro and Vicente Simón.

Experience

💼 Maria A. Aguilar has had a distinguished academic career, starting as a Professor Titular at the University of Valencia in 2002 and later being promoted to Full Professor in 2017. Her teaching and research primarily focus on psychobiology, particularly studying addiction, drug abuse, and neuroplasticity.

Research Focus

🔬 Her research explores the neurobiological mechanisms of addiction and stress, especially focusing on drug-seeking behavior, neuroplasticity, and the role of glutamatergic receptors. She has conducted extensive studies on the effects of cocaine, MDMA, and cannabidiol on the brain’s reward systems.

Awards and Honors

🏅 Professor Aguilar has received various accolades throughout her career, including recognition for her groundbreaking research in psychopharmacology and neurobiology. She is a member of several professional organizations and continues to contribute to advancing the understanding of brain mechanisms in behavior.

Publication Top Notes

📝 Top Publications:

Inhibition of Nitric Oxide Synthesis Prevents the Effects of Intermittent Social Defeat on Cocaine-Induced Conditioned Place Preference in Male Mice (2024). Published in Pharmaceuticals DOI: 10.3390/ph17091203. Cited by: 6 articles.

Intermittent voluntary wheel running promotes resilience to the negative consequences of repeated social defeat in mice (2022). Published in Physiology & Behavior DOI: 10.1016/j.physbeh.2022.113916. Cited by: 12 articles.

Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice (2021). Published in Journal of Psychopharmacology DOI: 10.1177/0269881120965952. Cited by: 20 articles.

Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice (2019). Published in European Journal of Neuroscience DOI: 10.1111/ejn.14190. Cited by: 15 articles.

Conclusion:

María A. Aguilar is a highly suitable candidate for the Research for Women Award due to her extensive contributions to psychobiology, particularly in the study of drug addiction and stress-related behaviors. Her long academic career, leadership roles, and prolific publication record highlight her dedication to advancing research in neuroscience. To increase her chances of winning, focusing more on the gender-specific implications of her work and enhancing public outreach could further align her profile with the award’s goals.

Juan Valdivieso | Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Mr. Juan Valdivieso | Health Sciences | Best Researcher Award

Research Lead, Savana, Spain

Dr. Juan Valdivieso is a distinguished medical professional specializing in immunology and oncology. He completed his medical degree in Ecuador and furthered his education in Spain, where he gained expertise in immuno-oncology. With extensive experience in both clinical practice and research, Dr. Valdivieso is currently a Medical Research Lead at SavanaResearch, Madrid. His work, particularly in the areas of rheumatoid arthritis and CAR-T cell monitoring, has been published in renowned scientific journals.

Publication Profile

Scopus

Strengths for the Award:

  1. Extensive Research Background: Dr. Juan Luis Valdivieso Shephard has a strong research background, with several publications in prestigious journals like Rheumatology (Oxford) and Heliyon. His work covers critical areas such as immunology, oncology, and artificial intelligence in medical research.
  2. Diverse Clinical Experience: He has gained significant clinical experience through his residency in immunology, rotations in oncology, and work as a medical researcher. This practical experience complements his research, making his contributions valuable in both clinical and research settings.
  3. Active in Scientific Community: Dr. Valdivieso Shephard has actively participated in various national and international conferences, presenting his research findings. His involvement in these events highlights his commitment to advancing his field and sharing knowledge with the broader scientific community.
  4. Collaborative Researcher: He has collaborated with various experts, contributing to multi-author publications and book chapters. This ability to work in a team and contribute to significant scientific literature is a strong point in his favor.
  5. Language Proficiency: Proficiency in both Spanish and English enables him to engage with a broader audience, increasing the impact of his research internationally.

Areas for Improvement:

  1. Further Specialization: While Dr. Valdivieso Shephard has a broad research portfolio, focusing more deeply on a specific niche within immunology or oncology could enhance his expertise and make him a leading figure in that area.
  2. Leadership Roles: Taking on more leadership roles in research projects or professional organizations could strengthen his profile. Mentoring junior researchers and leading large-scale studies would further demonstrate his capabilities.
  3. Grant Acquisition: Securing more research grants and funding would not only boost his research endeavors but also underscore his ability to attract resources, a key criterion for many research awards.

Education 🎓

Dr. Valdivieso earned his medical degree from the University of Cuenca, Ecuador, in 2013. He later obtained the Spanish equivalency of his medical degree in 2016. He completed a residency in immunology at Hospital Universitario La Paz in Madrid, Spain, from 2017 to 2021, followed by a master’s degree in Immuno-Oncology from Universidad Rey Juan Carlos, which he completed in 2023.

Experience 🏥

Dr. Valdivieso’s career began in Ecuador, where he served as a rural physician and later as an Onco-hematology doctor at Hospital José Carrasco Arteaga. Since 2021, he has been the Medical Research Lead at SavanaResearch in Madrid, Spain. His professional background also includes occasional teaching roles at MIR MediPlus.

Research Focus 🔬

Dr. Valdivieso’s research primarily focuses on immunology, oncology, and the application of artificial intelligence in medical research. His notable projects include studying anti-TNF treatment responses in rheumatoid arthritis and standardizing CAR-T cell monitoring techniques.

Awards and Honors 🏅

Throughout his career, Dr. Valdivieso has received recognition for his contributions to medical research, particularly in the field of immunology. His work has been cited in numerous scientific publications, reflecting the impact of his research on the medical community.

Publication Top Notes 📚

“Colitis expands the phenotype of PAAND patients: new case report and review of the literature” – Rheumatology (Oxford), 2021
Cited by 5 articles

“Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual development” – Rheumatology, 2021
Cited by 7 articles

“Variants in CASP10, a diagnostic challenge: Single center experience and review of the literature” – Clinical Immunology, 2021
Cited by 4 articles

“Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parameters” – Heliyon, 2024
Cited by 3 articles

“The challenge of standardizing CAR-T cell monitoring: A comparison of two flow-cytometry methods and correlation with qPCR technique” – Cytometry Part A, 2024
Cited by 2 articles

Conclusion:

Dr. Juan Luis Valdivieso Shephard is a strong candidate for the Best Researcher Award, given his extensive research experience, active participation in the scientific community, and contributions to immunology and oncology. His strengths, particularly in research and collaboration, make him a worthy contender. However, focusing on further specialization and leadership in research could enhance his candidacy for future awards.